Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Somatostatin Receptor PET/CT Imaging for the Detection and Staging of Pancreatic NET: A Systematic Review and Meta-Analysis
Matteo Bauckneht, Domenico Albano, Salvatore Annunziata, et al.
Diagnostics (2020) Vol. 10, Iss. 8, pp. 598-598
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics—Where We Are at and Where We Are Heading: A Systematic Review
Marko Magdi Abdou Sidrak, Maria Silvia De Feo, Ferdinando Corica, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3863-3863
Open Access | Times Cited: 24
Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy
Yuheng Hu, Ye Zeng, Fei Wang, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 45
[68Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [177Lu]DOTATOC PRRT: The “Theragnomics” Concept
Riccardo Laudicella, Albert Comelli, Virginia Liberini, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 984-984
Open Access | Times Cited: 31
Radiolabeled Somatostatin Analogues for Diagnosis and Treatment of Neuroendocrine Tumors
Valentina Ambrosini, Lucia Zanoni, Angelina Filice, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 1055-1055
Open Access | Times Cited: 27
Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors
Diletta Calabrò, Giulia Argalia, Valentina Ambrosini
Diagnostics (2020) Vol. 10, Iss. 12, pp. 1059-1059
Open Access | Times Cited: 39
The Challenge of Evaluating Response to Peptide Receptor Radionuclide Therapy in Gastroenteropancreatic Neuroendocrine Tumors: The Present and the Future
Virginia Liberini, Martin W. Huellner, Séréna Grimaldi, et al.
Diagnostics (2020) Vol. 10, Iss. 12, pp. 1083-1083
Open Access | Times Cited: 37
PET with Different Radiopharmaceuticals in Neuroendocrine Neoplasms: An Umbrella Review of Published Meta-Analyses
Giorgio Treglia, Ramin Sadeghi, Francesco Giovinazzo, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5172-5172
Open Access | Times Cited: 32
Dual Tracer 68Ga-DOTATOC and 18F-FDG PET Improve Preoperative Evaluation of Aggressiveness in Resectable Pancreatic Neuroendocrine Neoplasms
Paola Mapelli, Stefano Partelli, Matteo Salgarello, et al.
Diagnostics (2021) Vol. 11, Iss. 2, pp. 192-192
Open Access | Times Cited: 30
Somatostatin Receptor Targeted PET-CT and Its Role in the Management and Theranostics of Gastroenteropancreatic Neuroendocrine Neoplasms
Aadil Adnan, Sandip Basu
Diagnostics (2023) Vol. 13, Iss. 13, pp. 2154-2154
Open Access | Times Cited: 11
Diagnostic Management of Gastroenteropancreatic Neuroendocrine Neoplasms: Technique Optimization and Tips and Tricks for Radiologists
Fabio Pellegrino, Vincenza Granata, Roberta Fusco, et al.
Tomography (2023) Vol. 9, Iss. 1, pp. 217-246
Open Access | Times Cited: 10
Multimodal Imaging Approach to MEN-1 Syndrome-Associated Tumors
Anna Caterina Carli, Elisa Boffa, Matteo Bonatti, et al.
Diagnostics (2025) Vol. 15, Iss. 9, pp. 1164-1164
Open Access
Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer
Massimiliano Pacilio, Miriam Conte, Viviana Frantellizzi, et al.
Diagnostics (2022) Vol. 12, Iss. 7, pp. 1763-1763
Open Access | Times Cited: 14
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial
Luca Urso, Stefano Panareo, Angelo Castello, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2009-2009
Open Access | Times Cited: 13
Role of Exendin-4 Functional Imaging in Diagnosis of Insulinoma: A Systematic Review
Marko Magdi Abdou Sidrak, Maria Silvia De Feo, Ferdinando Corica, et al.
Life (2023) Vol. 13, Iss. 4, pp. 989-989
Open Access | Times Cited: 7
Diagnostic performance of PET/CT in the detection of liver metastases in well-differentiated NETs
Freba Grawe, Natalie Rosenberger, Maria Ingenerf, et al.
Cancer Imaging (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Radiolabeled Somatostatin Analogs for Cancer Imaging
Aamir Nazar, Sandip Basu
Seminars in Nuclear Medicine (2024) Vol. 54, Iss. 6, pp. 914-940
Closed Access | Times Cited: 2
Structured Reporting of Computed Tomography and Magnetic Resonance in the Staging of Pancreatic Adenocarcinoma: A Delphi Consensus Proposal
Vincenza Granata, Giovanni Morana, Mirko D’Onofrio, et al.
Diagnostics (2021) Vol. 11, Iss. 11, pp. 2033-2033
Open Access | Times Cited: 13
Gastroenteropancreatic Neuroendocrine Tumor Diagnosis
Asha Kandathil, Rathan M. Subramaniam
PET Clinics (2022) Vol. 18, Iss. 2, pp. 189-200
Closed Access | Times Cited: 9
The Role of 68Ga-DOTA-SSA PET/CT in the Management and Prediction of Peptide Receptor Radionuclide Therapy Response for Patients With Neuroendocrine Tumors
Osher Ngo Yung Lee, Kel Vin Tan, Vrijesh Tripathi, et al.
Clinical Nuclear Medicine (2022) Vol. 47, Iss. 9, pp. 781-793
Closed Access | Times Cited: 9
The Challenge of Evaluating Response to Peptide Receptor Radionuclide Therapy in Gastroenteropancreatic Neuroendocrine Tumors: The Present and the Future.
Virginia Liberini, Martin Hüllner, Séréna Grimaldi, et al.
(2020)
Open Access | Times Cited: 11
Detection of Bone Metastases by 68Ga‐DOTA‐SSAs and 18F‐FDG PET/CT: A Two‐Center Head‐to‐Head Study of Gastroenteropancreatic Neuroendocrine Neoplasms
Rui Tian, Qing Xie, Fei Yu, et al.
Contrast Media & Molecular Imaging (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 7
Surgical Management and Long-Term Evaluation of Pancreatic Neuroendocrine Tumors
Shadin Ghabra, Bhavishya Ramamoorthy, Stephen G. Andrews, et al.
Surgical Clinics of North America (2024) Vol. 104, Iss. 4, pp. 891-908
Closed Access | Times Cited: 1
National practice patterns in the use of endoscopic ultrasound biopsy for resectable Pancreatic Neuroendocrine Tumors: Insights into the role of DOTATATE PET/CT in diagnosis
Megan Casey, Audrey Brown, Fernanda Romero‐Hernández, et al.
The American Journal of Surgery (2024) Vol. 235, pp. 115779-115779
Open Access | Times Cited: 1
Imaging in translational cancer research
Felix T. Kurz, Heinz‐Peter Schlemmer
Cancer Biology and Medicine (2022) Vol. 19, Iss. 11, pp. 1565-1585
Open Access | Times Cited: 4
Clinical value of 18F-FDG PET/CT to predict MYCN gene, chromosome 1p36 and 11q status in pediatric neuroblastoma and ganglioneuroblastoma
Jiazhong Ren, Zheng Fu, Yaqing Zhao
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top